Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,990 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark case.
Song YC, Hu ZH, Yan XN, Fang H, Tang Y, Jing H, Men K, Zhang N, Zhang J, Jin J, Zhong QZ, Ma J, Yang WF, Zhong YH, Dong LH, Wang XH, Wu HF, Du XH, Hou XR, Tie J, Lu YF, Zhao LN, Li YX, Wang SL. Song YC, et al. Among authors: fang h. Radiat Oncol. 2023 Nov 29;18(1):194. doi: 10.1186/s13014-023-02379-1. Radiat Oncol. 2023. PMID: 38031125 Free PMC article. Clinical Trial.
Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy.
Zhou YM, Liu X, Yang Y, Wang SL, Fang H, Song YW, Liu YP, Jin J, Li N, Lu NN, Jing H, Tang Y, Chen B, Zhang WW, Zhai YR, Men K, Dai JR, Deng M, Qi SN, Li YX. Zhou YM, et al. Among authors: fang h. J Cancer Res Clin Oncol. 2023 Jul;149(8):5219-5230. doi: 10.1007/s00432-022-04472-6. Epub 2022 Nov 14. J Cancer Res Clin Oncol. 2023. PMID: 36374333
Risk stratification and prognostic value of multi-modal MRI-based radiomics for extranodal nasal-type NK/T-cell lymphoma.
Zhao YT, Chen SY, Liu X, Yang Y, Chen B, Song YW, Fang H, Jin J, Liu YP, Jing H, Tang Y, Li N, Lu NN, Wang SL, Ouyang H, Hu C, Liu J, Wang Z, Chen F, Yin L, Zhong QZ, Men K, Dai JR, Qi SN, Li YX. Zhao YT, et al. Among authors: fang h. BMC Cancer. 2023 Jan 25;23(1):88. doi: 10.1186/s12885-023-10557-3. BMC Cancer. 2023. PMID: 36698118 Free PMC article.
The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I-III triple-negative breast cancer.
Sun GY, Zhang J, Wang BZ, Jing H, Fang H, Tang Y, Song YW, Jin J, Liu YP, Tang Y, Qi SN, Chen B, Lu NN, Li N, Li YX, Ying JM, Wang SL. Sun GY, et al. Among authors: fang h. Br J Cancer. 2023 Jun;128(11):2044-2053. doi: 10.1038/s41416-023-02218-w. Epub 2023 Mar 25. Br J Cancer. 2023. PMID: 36966236 Free PMC article.
Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation Therapy.
Wang DQ, Zhang N, Dong LH, Zhong YH, Wu HF, Zhong QZ, Jin J, Hou XR, Jing H, Tang Y, Hu C, Song YW, Liu YP, Qi SN, Tang Y, Lu NN, Chen B, Zhai YR, Zhang WW, Li N, Fang H, Li YX, Wang SL. Wang DQ, et al. Among authors: fang h. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):186-197. doi: 10.1016/j.ijrobp.2023.03.060. Epub 2023 Mar 30. Int J Radiat Oncol Biol Phys. 2023. PMID: 37001764 Free article.
Voluntary Deep Inspiration Breath-Hold (VDIBH) Whole-Breast Irradiation Assisted by Optical Surface Monitoring System (OSMS) in Patients With Left-Sided Breast Cancer: A Prospective Phase II Study.
Zhang JH, Li TT, Qin SR, Liu ZQ, Chen SY, Song YW, Tang Y, Jing H, Fang H, Zhao XR, Jin J, Liu YP, Tang Y, Qi SN, Li N, Chen B, Lu NN, Li YX, Wang SL. Zhang JH, et al. Among authors: fang h. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231173773. doi: 10.1177/15330338231173773. Technol Cancer Res Treat. 2023. PMID: 37312511 Free PMC article. Clinical Trial.
Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab era.
Wang X, Liu X, Zhong QZ, Wu T, Wu YP, Yang Y, Chen B, Jing H, Tang Y, Jin J, Liu YP, Song YW, Fang H, Lu NN, Li N, Zhai YR, Zhang WW, Wang SL, Chen F, Qi SN, Li YX. Wang X, et al. Among authors: fang h. Radiother Oncol. 2023 Nov;188:109902. doi: 10.1016/j.radonc.2023.109902. Epub 2023 Sep 9. Radiother Oncol. 2023. PMID: 37678622
Prediction of 5-year overall survival of diffuse large B-cell lymphoma on the pola-R-CHP regimen based on 2-year event-free survival and progression-free survival.
Zhang WR, Liu X, Zhong QZ, Wu T, Yang Y, Chen B, Jing H, Tang Y, Jin J, Liu YP, Song YW, Fang H, Lu NN, Li N, Zhai YR, Zhang WW, Wang SL, Chen F, Yin L, Qi SN, Li YX. Zhang WR, et al. Among authors: fang h. Cancer Med. 2024 Jan 5;13(1):e6899. doi: 10.1002/cam4.6899. Online ahead of print. Cancer Med. 2024. PMID: 38180169 Free PMC article.
6,990 results